C12N 2501/2316
Interleukin-16
Official title: Interleukin-16 (IL-16)
C12N2501/2316 (Interleukin-16) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 3
- Assignees
- 4
- Inventors
- 12
- Latest grant
- 20 Sep 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
By publication year.
Recent patents
- Method of producing tumor-reactive t cell composition using modulatory agents2 Feb 2023US 2023/0032934 A1Myst Therapeutics, LLC
- Regulated biocircuit systems27 Jun 2019US 2019/0192691 A1Obsidian Therapeutics, Inc.
- Muscle stem cell in vitro culture method and application23 Jun 2016US 2016/0177266 A1Shanghai Institutes for Biological Sciences, Chine SE Academy of Sciences
Most cited
By later US patents